Ensysce Biosciences Inc expected to post a loss of 93 cents a share - Earnings Preview

Ensysce Biosciences

19/03/2024 12:42

* Ensysce Biosciences Inc  ENSC.OQ   ENSC.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 21
for the period ending March 31 2024
    * The La Jolla California-based  company is expected to
report a
49.4% decrease in revenue to $400 thousand from $790 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Ensysce Biosciences Inc
is for
a loss of 93 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ensysce
Biosciences Inc is $16.30​, above​ its last closing price
of $0.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023              -0.87      -1.37     Missed  -57.5
 Sep. 30 2023  -1.04       -1.06      -0.87     Beat    17.7
 Jun. 30 2023  -2.50       -2.73      -0.98     Beat    64.1​
 Mar. 31 2023  -5.44       -5.08      -2.08     Beat    59
 ​​Dec.        -30.85      -28.88     -18.24    Beat    36.8
 31 2022                                                
 Sep. 30 2022  -38.40      -38.40     -8.88     Beat    76.9​
 Jun. 30 2022  -31.20      -40.80     -57.60    Missed  -41.2
 Mar. 31 2022  -38.40      -38.40     -14.40    Beat    62.5
 This summary was machine generated March 19 at 12:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)